Reported 293,500 shares, up 2,577 (0.9%) from the prior quarter.
Reported value -5.9%; share count 0.9% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 26239000 |
| 2021-12-31 | 24681000 |
| 2022-03-31 | 20317000 |
| 2022-06-30 | 15643000 |
| 2022-09-30 | 15145000 |
| 2022-12-31 | 22958368 |
| 2023-03-31 | 21796435 |
| 2023-06-30 | 30266124 |
| 2023-09-30 | 22775573 |
| 2023-12-31 | 28882132 |
| 2024-03-31 | 27152617 |
| 2024-06-30 | 22559996 |
| 2024-09-30 | 29791354 |
| 2024-12-31 | 19615768 |
| 2025-03-31 | 18997106 |
| 2025-06-30 | 15647126 |
| 2025-09-30 | 13497408 |
| 2025-12-31 | 9472849 |
| 2026-03-31 | 6243770 |
| 2026-06-30 | 4779945 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Reduced | 143,155 | -154,877 (-52.0%) | 0.02% | $4,779,945 | 2026-08-14 | |
| Q1 2026 | Reduced | 298,032 | -113,831 (-27.6%) | 0.03% | $6,243,770 | 2026-05-15 | |
| Q4 2025 | Reduced | 411,863 | -36,854 (-8.2%) | 0.04% | $9,472,849 | 2026-02-17 | |
| Q3 2025 | Added | 448,717 | +18,378 (4.3%) | 0.05% | $13,497,408 | 2025-11-14 | |
| Q2 2025 | Reduced | 430,339 | -94,298 (-18.0%) | 0.07% | $15,647,126 | 2025-08-14 | |
| Q1 2025 | Added | 524,637 | +58,372 (12.5%) | 0.11% | $18,997,106 | 2025-05-16 | |
| Q4 2024 | Reduced | 466,265 | -70,033 (-13.1%) | 0.09% | $19,615,768 | 2025-02-14 | |
| Q3 2024 | Reduced | 536,298 | -12,607 (-2.3%) | 0.14% | $29,791,354 | 2024-11-14 | |
| Q2 2024 | Reduced | 548,905 | -32,646 (-5.6%) | 0.11% | $22,559,996 | 2024-08-14 | |
| Q1 2024 | Reduced | 581,551 | -22,425 (-3.7%) | 0.13% | $27,152,617 | 2024-05-15 | |
| Q4 2023 | Reduced | 603,976 | -34,890 (-5.5%) | 0.16% | $28,882,132 | 2024-02-14 | |
| Q3 2023 | Reduced | 638,866 | -17,239 (-2.6%) | 0.13% | $22,775,573 | 2023-11-14 | |
| Q2 2023 | Added | 656,105 | +112,553 (20.7%) | 0.15% | $30,266,124 | 2023-08-14 | |
| Q1 2023 | Added | 543,552 | +48,012 (9.7%) | 0.12% | $21,796,435 | 2023-05-15 | |
| Q4 2022 | Added | 495,540 | +129,827 (35.5%) | 0.12% | $22,958,368 | 2023-02-14 | |
| Q3 2022 | Added | 365,713 | +103,512 (39.5%) | 0.08% | $15,145,000 | 2022-11-15 | |
| Q2 2022 | Reduced | 262,201 | -17,572 (-6.3%) | 0.07% | $15,643,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 279,773 | -13,727 (-4.7%) | 0.06% | $20,317,000 | 2022-05-16 | |
| Q4 2021 | Added | 293,500 | +2,577 (0.9%) | 0.06% | $24,681,000 | 2022-02-14 | |
| Q3 2021 | Added | 290,923 | +99,491 (52.0%) | 0.06% | $26,239,000 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
247 managers reported ULTRAGENYX PHARMACEUTICAL INC for Q4 2021.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC MD | Added | 11,525,089 | +66,043 | 0.09% | $969,145,000 | 32 qtrs |
| VANGUARD GROUP INC | Added | 5,920,568 | +45,737 | 0.01% | $497,860,000 | 32 qtrs |
| Capital International Investors | Reduced | 5,369,774 | -295,419 | 0.1% | $451,547,000 | 22 qtrs |
| FEDERATED HERMES INC | Reduced | 3,986,870 | -162 | 0.62% | $335,256,000 | 32 qtrs |
| BlackRock Inc | Added | 3,484,652 | +34,099 | < 0.01% | $293,025,000 | 32 qtrs |
| WELLINGTON MANAGEMENT GROUP LLP | Added | 2,877,403 | +369,128 | 0.04% | $241,961,000 | 32 qtrs |
| Clearbridge Investments LLC | Added | 2,778,859 | +413,238 | 0.16% | $233,674,000 | 25 qtrs |
| Capital World Investors | Reduced | 2,766,844 | -17 | 0.04% | $232,664,000 | 20 qtrs |
| ALKEON CAPITAL MANAGEMENT LLC | Unchanged | 2,308,130 | 0 | 0.36% | $194,091,000 | 15 qtrs |
| STATE STREET CORPORATION | Added | 1,678,841 | +204,976 | < 0.01% | $141,174,000 | 32 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2021
- Filed
- February 14, 2022
- Filing type
- 13F-HR
- Position type
- Common
Voting authority reported
- Sole
- 233,876
- Shared
- 0
- None
- 59,624
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.